Functional Remodeling Following Myofilament Calcium Sensitization in Rats with Volume Overload Heart Failure DISSERTATION Presen

Total Page:16

File Type:pdf, Size:1020Kb

Functional Remodeling Following Myofilament Calcium Sensitization in Rats with Volume Overload Heart Failure DISSERTATION Presen Functional Remodeling Following Myofilament Calcium Sensitization in Rats with Volume Overload Heart Failure DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Kristin Diane Lewis, D.V.M. Graduate Program in Comparative and Veterinary Medicine The Ohio State University 2014 Dissertation Committee: Pamela Lucchesi, Advisor Christopher Breuer Christopher Premanandan Lynette Rogers Copyrighted by Kristin Diane Lewis 2014 Abstract Hemodynamic volume overload (VO) is characterized by left ventricular (LV) dilation, progressive LV dysfunction, and heart failure (HF). In the aortocaval fistula (ACF) model of VO HF, LV dysfunction is accompanied by a variety of changes at the myocyte level including myofilament proteins including decreased α-to-β-myosin heavy chain (MHC) expression, decreased myofilament Ca2+ sensitivity and altered regulation of intercalated disc proteins involved in electromechanical coupling. While pharmacologic therapy alone cannot resolve the hemodynamic overload in human patients or in animal models, pre-operative pharmacologic therapy may delay time to surgical intervention, and post-operative pharmacologic therapy may accelerate functional recovery. Current therapies that target neurohormonal pathway activation provide some relief but do not reverse the decreased cardiac contractility, the central feature of systolic HF [60]. Targeting neurohormonal pathway activation can result in increased myocardial oxygen consumption and myocardial Ca2+ overload [140], and therefore it is necessary to investigate drugs that have alternative mechanisms of action. Levosimendan (Levo) stabilizes Ca2+-saturated troponin C (cTnC) prolonging its interaction with cardiac troponin I (cTnI), which promotes contractile force without increasing the intracellular Ca2+ transient amplitude or myocardial oxygen consumption [126,128,136]. Given these overall factors, my hypothesis is that therapeutic strategies such as Levo that target ii myofilament Ca2+ sensitization will preserve/improve LV function in VO HF. To test this hypothesis, three specific aims were proposed: 1) determine if short-term Levo treatment would preserve/improve LV function in rats with ACF-induced pre-HF or reversed pre- HF (Chapter 2), 2) determine if Levo could improve the detrimental effects of delayed reversal (Chapter 3), and 3) determine if chronic Levo treatment would preserve LV function when initiated in rats with ACF-induced pre-HF or established HF (Chapter 4). Sham and ACF surgery were performed at Week 0 following by Levo treatment with and without hemodynamic load reduction surgery (reversal) at various timepoints. Continued Levo improved systolic and diastolic function regardless of the treatment starting point and hemodynamic load. Improved LV function variably correlated with increased myofilament Ca2+ sensitivity, cMyBP-C/cTnI phosphorylation and normalization of α-to- β-MHC. Finally, speckle-tracking echocardiographic analysis suggests that Levo improves short-axis, but not long-axis function at end-stage HF. Because of the improved LV function with Levo, with and without hemodynamic load reduction, Levo offers a new therapeutic option in patients with VO HF. More broadly, therapeutic strategies targeting myofilament Ca2+ sensitization may provide a new therapeutic target for patients with volume overload heart failure. iii To my husband Travis, my family, and many others for your unwavering patience, love and support through the many highs and lows of this journey. iv Acknowledgments I would like to thank my advisor, Dr. Pamela Lucchesi, the members of my graduate committee, and the members of the Lucchesi lab for their support in the design and execution of the experiments done in this dissertation. I would like to thank the faculty veterinary pathologists at The Ohio State University who have been instrumental in developing and shaping my skills as a veterinary pathologist, and I would like to thank my resident-mates who walked through this journey with me. I would like those who pushed me to become a veterinary pathologist, especially NOD who taught me to ask the question, ―What’s your hypothesis?‖ Finally, I would like to thank my friends and family whose unwavering support and encouragement have helped me through the highs and lows of my educational journey. v Vita 2001................................................................B.S. Microbiology, California Polytechnic State University 2001-2006 ......................................................Research Associate, Genentech, Inc 2010................................................................D.V.M., University of California Davis, School of Veterinary Medicine 2010 to present ..............................................Veterinary Anatomic Pathology Resident, Graduate Research Associate, Department of Veterinary Biosciences, The Ohio State University Publications Wilson K, Lucchesi PA. Myofilament dysfunction as an emerging mechanism of volume overload heart failure. Pflugers Arch. 2014 Feb 1. [Epub ahead of print] PMID: 24488008 Fields of Study Major Field: Comparative and Veterinary Medicine vi Table of Contents Abstract ............................................................................................................................... ii Dedication .......................................................................................................................... iv Acknowledgments............................................................................................................... v Vita ..................................................................................................................................... vi List of Tables ................................................................................................................... xiv List of Figures ................................................................................................................... xv Chapter 1: Introduction and Background ...................................................................... 1 Abstract ............................................................................................................................... 1 Introduction ......................................................................................................................... 1 Rodent and non-rodent animal models are used to study VO-HF ............................... 4 Neurohormonal activation in volume overload ........................................................... 5 Volume overload physiology and structural alterations differs from pressure overload ....................................................................................................................... 6 LV pump function in VO............................................................................................. 7 Cardiomyocyte dysfunction in VO ..................................................................................... 9 Excitation-contraction coupling .................................................................................. 9 vii VO HF, intercalated discs and electromechanical transmission ................................ 10 Gap junctions/electrical communication ................................................................... 12 Force transmission through the intercalated disc ...................................................... 13 Myofilament dysfunction in VO ....................................................................................... 14 Force generation ........................................................................................................ 14 DCM-causing mutation in thin filament proteins ...................................................... 16 Thick filament proteins in VO HF ............................................................................. 20 Passive muscle stiffness in VO ......................................................................................... 24 Extracellular matrix (ECM) alterations in VO.................................................................. 24 ECM turnover ............................................................................................................ 24 Mechanical stress-induced ECM remodeling ............................................................ 26 Mast cells and VO-induced ECM remodeling .......................................................... 28 Mast cells and paracrine-induced LV ECM remodeling ........................................... 30 Pharmacologic therapy in VO ........................................................................................... 31 Diuretics..................................................................................................................... 31 Vasodilators ............................................................................................................... 31 β-adrenergic antagonists ............................................................................................ 32 Myofilament Ca2+ sensitizers .................................................................................... 32 Myosin activators ...................................................................................................... 33 viii Phosphodiesterase inhibitors ..................................................................................... 33 Limitations and future directions .....................................................................................
Recommended publications
  • Cardiac Work and Contractility J
    Br Heart J: first published as 10.1136/hrt.30.4.443 on 1 July 1968. Downloaded from Brit. Heart 7., 1968, 30, 443. Cardiac Work and Contractility J. HAMER* It has been customary to regard the heart as a fibres is needed to maintain the stroke volume in a pump maintaining the flow of blood, and to assess larger ventricle, and ventricular work is correspon- the work done by the heart from the pressure and dingly reduced (Gorlin, 1962). Simple calcula- volume of blood leaving the ventricles. While cor- tions suggest that there is, in fact, little change in rect in physical terms, measurement of external work as the ventricle dilates (Table). The more cardiac work in this way is a poor index of the myo- forceful contraction produced by increased stretch- cardial oxygen consumption which is related to the ing of the muscle fibres through the Starling work done by the ventricular muscle. Systolic mechanism probably gives the dilated ventricle a pressure seems to be a more important determinant functional advantage. of ventricular work than stroke volume, and under Estimates of ventricular work based on force some conditions myocardial oxygen consumption measurements still give an incomplete picture of can be predicted from the systolic pressure, duration myocardial behaviour, as a rapid contraction needs of systole, and heart rate (Sarnoff et al., 1958). more energy than a slow one. The velocity of This relationship does not hold in other situations, contraction of the muscle fibres is an important as ventricular work depends on the force of the con- additional determinant of myocardial oxygen con- traction in the ventricular wall rather than on the sumption (Sonnenblick, 1966).
    [Show full text]
  • Time-Varying Elastance and Left Ventricular Aortic Coupling Keith R
    Walley Critical Care (2016) 20:270 DOI 10.1186/s13054-016-1439-6 REVIEW Open Access Left ventricular function: time-varying elastance and left ventricular aortic coupling Keith R. Walley Abstract heart must have special characteristics that allow it to respond appropriately and deliver necessary blood flow Many aspects of left ventricular function are explained and oxygen, even though flow is regulated from outside by considering ventricular pressure–volume characteristics. the heart. Contractility is best measured by the slope, Emax, of the To understand these special cardiac characteristics we end-systolic pressure–volume relationship. Ventricular start with ventricular function curves and show how systole is usefully characterized by a time-varying these curves are generated by underlying ventricular elastance (ΔP/ΔV). An extended area, the pressure– pressure–volume characteristics. Understanding ventricu- volume area, subtended by the ventricular pressure– lar function from a pressure–volume perspective leads to volume loop (useful mechanical work) and the ESPVR consideration of concepts such as time-varying ventricular (energy expended without mechanical work), is linearly elastance and the connection between the work of the related to myocardial oxygen consumption per beat. heart during a cardiac cycle and myocardial oxygen con- For energetically efficient systolic ejection ventricular sumption. Connection of the heart to the arterial circula- elastance should be, and is, matched to aortic elastance. tion is then considered. Diastole and the connection of Without matching, the fraction of energy expended the heart to the venous circulation is considered in an ab- without mechanical work increases and energy is lost breviated form as these relationships, which define how during ejection across the aortic valve.
    [Show full text]
  • Use of Analogy to Teach the Compensatory Mechanisms of the Heart in Heart Failure
    Saving Christmas: Use of Analogy to Teach The Compensatory Mechanisms of the Heart in Heart Failure. Krista L. Rompolski* *Corresponding Author: [email protected] HAPS Educator. Vol 22 (2), pp. 171-175. Published August 2018. doi: 10.21692/haps.2018.015 Rompolski K.L. (2018). Saving Christmas: Use of Analogy to Teach The Compensatory Mechanisms of the Heart in Heart Failure. HAPS Educator 22 (2): 171-175. doi: 10.21692/haps.2018.015 Saving Christmas: Use of Analogy to Teach The Compensatory Mechanisms of the Heart in Heart Failure Krista L. Rompolski, PhD, Drexel University, 1601 Cherry Street, Room 9115 Philadelphia, PA 19102 [email protected] Abstract Students of physiology are taught that the body’s homeostatic mechanisms are in place to maintain the body’s internal environment. This is most often associated with maintaining health. Congestive Heart Failure represents a disease in which the body’s homeostatic mechanisms worsen the progression of the disease. Using the analogy of Santa Claus delivering presents around the world in a single evening, students can gain a better understanding of how the body’s attempt to respond to a deviation from homeostasis, the decrease in cardiac output, may drive the progression of the disease. https://doi.org/10.21692/haps.2018.015 Key words: cardiac output, stroke volume, heart failure, RAAS Introduction Students of physiology and biology are taught the concept mechanisms include activation of the sympathetic nervous of homeostasis. The term was coined by Walter Cannon in system, ventricular hypertrophy with chronic remodeling, and 1932 in The Wisdom of the Body and used to describe the increased preload through activation of the renin-angiotensin- internal constancy of the body.
    [Show full text]
  • Cardiac Output
    Overview of Human Anatomy and Physiology: Cardiac Output Introduction Welcome to the Overview of Human Anatomy and Physiology course on the Cardiac System. This module, Cardiac Output, discusses measurement of heart activity and factors that affect activity. After completing this module, you should be able to: 1. Define stroke volume and cardiac output. 2. Discuss the relationship between heart rate, stroke volume, and cardiac output. 3. Identify the factors that control cardiac output. Measurement Cardiac Output The activity of the heart can be quantified to provide information on its health and efficiency. One important measurement is cardiac output (CO), which is the volume of blood ejected by the left ventricle each minute. Heart rate and stroke volume determine cardiac output. Heart rate (HR) is the number of heartbeats in one minute. The volume of blood ejected by the left ventricle during a heartbeat is the stroke volume (SV), which is measured in milliliters. Equation Cardiac output is calculated by multiplying the heart rate and the stroke volume. Average Values Cardiac output is the amount of blood pumped by the left ventricle--not the total amount pumped by both ventricles. However, the amount of blood within the left and right ventricles is almost equal, approximately 70 to 75 mL. Given this stroke volume and a normal heart rate of 70 beats per minute, cardiac output is 5.25 L/min. Relationships When heart rate or stroke volume increases, cardiac output is likely to increase also. Conversely, a decrease in heart rate or stroke volume can decrease cardiac output. What factors regulate increases and decreases in cardiac output? Regulation Factors Regulating Cardiac Output Factors affect cardiac output by changing heart rate and stroke volume.
    [Show full text]
  • Drugs That Affect the Cardiovascular System
    PharmacologyPharmacologyPharmacology DrugsDrugs thatthat AffectAffect thethe CardiovascularCardiovascular SystemSystem TopicsTopicsTopics •• Electrophysiology Electrophysiology •• Vaughn-Williams Vaughn-Williams classificationclassification •• Antihypertensives Antihypertensives •• Hemostatic Hemostatic agentsagents CardiacCardiacCardiac FunctionFunctionFunction •• Dependent Dependent uponupon –– Adequate Adequate amountsamounts ofof ATPATP –– Adequate Adequate amountsamounts ofof CaCa++++ –– Coordinated Coordinated electricalelectrical stimulusstimulus AdequateAdequateAdequate AmountsAmountsAmounts ofofof ATPATPATP •• Needed Needed to:to: –– Maintain Maintain electrochemicalelectrochemical gradientsgradients –– Propagate Propagate actionaction potentialspotentials –– Power Power musclemuscle contractioncontraction AdequateAdequateAdequate AmountsAmountsAmounts ofofof CalciumCalciumCalcium •• Calcium Calcium isis ‘glue’‘glue’ that that linkslinks electricalelectrical andand mechanicalmechanical events.events. CoordinatedCoordinatedCoordinated ElectricalElectricalElectrical StimulationStimulationStimulation •• Heart Heart capablecapable ofof automaticityautomaticity •• Two Two typestypes ofof myocardialmyocardial tissuetissue –– Contractile Contractile –– Conductive Conductive •• Impulses Impulses traveltravel throughthrough ‘action‘action potentialpotential superhighway’.superhighway’. A.P.A.P.A.P. SuperHighwaySuperHighwaySuperHighway •• Sinoatrial Sinoatrial node node •• Atrioventricular Atrioventricular nodenode •• Bundle Bundle ofof
    [Show full text]
  • 1999 Handbook
    The Australian Short Course on Intensive Care Medicine 1999 Handbook The Australian Short Course on Intensive Care Medicine 1999 Handbook Editor L.I.G. Worthley Published in 1999 by The Australasian Academy of Critical Care Medicine Department of Critical Care Medicine Flinders Medical Centre, Bedford Park South Australia 5042 ISSN 1327-4759 1999 The Australasian Academy of Critical Care Medicine Requests to reproduce original material should be addressed to the publisher. Printed by Gillingham Printers Pty Ltd 153 Holbrooks Road Underdale South Australia 5032 CONTENTS Page Chapter 1. Cardiac anatomy 1 Chapter 2. Physiology of myocardial contractility 7 Chapter 3. Cardiac output and oxygen delivery 25 Chapter 4. The autonomic nervous system 49 Trainee Presentations 67 Index 131 iii iv 1999 SHORT COURSE PROGRAMME March 22nd 23rd 24th 25th 26th FMC QEH RAH RAH FMC 0815 Travel to Travel to Travel to FMC QEH FMC 0900 Lecture Interactive Lecture Lecture Lecture Examination of Management of Diagnosis & ] the critically ill Clinical adult neurotrauma of nosocomial Acute liver patient vignettes J.M pneumonia failure L W. L.W. M.C. A.H 1015 Lecture Interactive Clinical cases Interactive Interactive Biochemistry, J.M M.C In defence of Blood gases, ---------------------- Clinical cases Acid base & Blood Pressure Bacteriology Trauma vignettes Blood gases A.B B.V. B.G. M.F L.W 1130 Clinical cases Interactive Lecture Interactive Interactive A.V A.H B.V L.W --------------------- X-rays Organ donation Pathology, X Presentat’ns Respiratory rays, ECG’s assistance in airflow L.W. R.Y M.F L. W obstruction A.B 1245 Lunch Travel to WCH 1400 Interactive Lecture Lecture Lecture Common ECG's Outcome ARDS update paediatric Prediction ICU problems L.W J.M M.C N.M 1515 Lecture Interactive Clinical cases Short questions Understanding M.F R.Y Fluid & Asthma and ---------------------- N.M.
    [Show full text]
  • Cardiovascular Failure, Inotropes and Vasopressors
    Cardiovascular failure, inotropes and vasopressors Introduction thetensionintheventricularwallduring nantly affected by extrinsic factors sum- Cardiovascularfailure(‘shock’)meansthat diastoleastheheartfillswithbloodresult- marizedinTable 2. tissue perfusion is inadequate to meet inginstretchingofcardiacmusclefibres. metabolicdemandsforoxygenandnutri- Stretchingthefibresincreasestheforceof Oxygen delivery ents.Ifuncorrectedthiscanleadtoirre- contractionduringthesubsequentsystole Adequate oxygen delivery is dependent versible tissue hypoxia and cell death. (Frank–Starlingmechanismoftheheart). onboththecardiacoutputandthearte- Cardiovascularfailureisacommonindica- Afterloadisthetensionintheventricu- rial oxygen content. Most oxygen trans- tionforadmissiontothecriticalcareunit. lar wall required to eject blood into the portedinthebloodisboundtohaemo- Theaimoftreatmentistosupporttissue aorta. This will vary depending on the globin.Agramoffully-saturatedhaemo- perfusionandoxygendeliverywhichcan volume of the ventricle, the thickness of globin can carry 1.34ml of oxygen. beachievedthroughtheuseofvasoactive thewall,increasedsystemicvascularresist- Oxygen will also be dissolved in the drugs(inotropesandvasopressors). ance and the presence of conditions that plasma but the amount is negligible at Inotropes increase cardiac contractility obstructoutflow(e.g.aorticstenosis). normalatmosphericpressuresandthere- and cardiac output while vasopressors Contractility is the intrinsic ability of fore disregarded. Therefore the arterial cause vasoconstriction
    [Show full text]
  • Role of Myocardial Contractions on Coronary Vasoactivity
    MCB, vol.16, supplemental 2, pp.84-86, 2019 Role of Myocardial Contractions on Coronary Vasoactivity Xiao Lu1,* and Ghassan Kassab1 California Medical Innovations Institute, San Diego, CA 92121, USA. Corresponding Author: Xiao Lu. Email: [email protected]. Keywords: Extrinsic Pressure; coronary arterioles; mechanotransduction; heart failure; myocardial contractility; tachycardia Background: Heart failure (HF) is accompanied by alteration of hemodynamic conditions, which is due to the triggers of complex reflex changes in the sympathetic, endocrine, and rennin systems [1–2]. A critical effect of HF is reduced blood flow (ischemia) in the cardiovascular system resulting from mild to severe reduction in cardiac output (CO) due to dysfunction of myocardial contractility. It is known that coronary flow is regulated by many factors, including metabolic demand, perfusion pressure, oxidative stress, etc. Vascular vasodilation and vasoconstriction change microcirculation resistance and therefore regulate coronary circulation. However, it is not clear whether myocardial contractility may affect coronary tone to regulate coronary circulation in HF, i.e., the role the extrinsic mechanics in coronary arteriole tone. It is recognized that the extrinsic compression on blood vessel wall during skeletal muscle contraction is an independent regulator of vascular tone (3-4). Myocardial contraction also leads to such compression on intra-myocardial arterioles. Therefore, we hypothesize that myocardial contractility will change the arteriole tone to regulate
    [Show full text]
  • Mechanical Properties of the Heart
    Page 1 of 17 MECHANICAL PROPERTIES OF THE HEART AND ITS INTERACTION WITH THE VASCULAR SYSTEM Daniel Burkhoff MD PhD, Columbia University Figures: Daniel Burkhoff, MD PhD/Jie Wang, MD PhD Recommended Reading: Guyton, A. Textbook of Medical Physiology, 10th Edition. Chapters 9, 14, 20. Berne & Levy. Principles of Physiology. 4th Edition. Chapter 23. Katz, AM. Physiology of the Heart, 3rd Edition. Chapter 15. Learning Objectives: 1. To understand the hemodynamic events occurring during the different phases of the cardiac cycle and to be able to explain these both on the pressure-volume diagram and on curves of pressure and volume versus time. 2. To understand how the end-diastolic pressure volume relationship (EDPVR) and the end-systolic pressure-volume relationship (ESPVR) characterize ventricular diastolic and systolic properties, respectively. 3. To understand the concepts of contractility, preload, afterload, compliance. 4. To understand what Frank-Starling Curves are, and how they are influenced by ventricular afterload and contractility. 5. To understand how afterload resistance can be represented on the PV diagram using the Ea concept and to understand how Ea can be used in concert with the ESPVR to predict how cardiac performance varies with contractility, preload and afterload. Glossary: Afterload The mechanical "load" on the ventricle during ejection. Under normal physiological conditions, this is determined by the arterial system. Indices of afterload include, aortic pressure, ejection wall stress, total peripheral resistance (TPR) and arterial impedance. Compliance A term used in describing diastolic properties ("stiffness") of the ventricle. Technically, it is defined as the reciprocal of the slope of the EDPVR ([dP/dV]-1).
    [Show full text]
  • INDE 221 Spring 2010 Syllabus Part 2
    Human Health & Disease Mondays, Tuesdays, Thursdays and Fridays 9:00 - 11:50 AM Lectures: Room M-112, Labs: Fleischmann IINNDDEE 222211 SSpprriinngg 22001100 Syllabus SSyyllllaabbuuss PPaarrtt 22 (2010) Year's Last Syllabus (2010) Year's Last Human Health & Disease Inde 221 Spring 2010 Table of Contents CARDIOVASCULAR BLOCK SYLLABUS SCHEDULE 7 SYLLABUS PREFACE 11 CARDIAC MUSCLE AND FHC 15 EXCITATION-CONTRACTION COUPLING Syllabus27 NERNST POTENTIAL AND OSMOSIS 43 EXCITABILITY AND CONDUCTION 51 CIRCULATORY VESSEL HISTOLOGY LAB 63 CARDIAC ACTION POTENTIAL 71 CONTROL OF HEART RHYTHM (2010) 85 AUTONOMIC DRUGS OVERVIEW I 97 ELECTROCARDIOGRAM (ECG) 99 LESIONS OF BLOOD VESSELS 109 THROMBOEMBOLIC DISEASE 117 CARDIAC REFLEXESYear's 123 AUTONOMIC DRUGS OVERVIEW II 141 ECG SMALL GROUPS 143 LastAUTONOMIC DRUGS: CHOLINERGICS 147 CARDIAC MUSCLE MECHANICS 149 AUTONOMIC DRUGS: ANTICHOLINERGICS 175 ARRHYTHMIAS 177 AUTONOMIC DRUGS: SYMPATHOMIMETICS I 203 VENTRICULAR PHYSIOLOGY 205 AUTONOMIC DRUGS: SYMPATHOMIMETICS II 235 STARLING CURVE AND VENOUS RETURN 237 CARDIAC OUTPUT AND CATHETERIZATION 245 AUTONOMIC DRUGS: ADRENOCEPTOR BLOCKERS 267 PHYSICS OF CIRCULATION Syllabus269 CASE DISCUSSIONS: AUTONOMIC DRUGS 289 SMOOTH MUSCLE 291 ISCHEMIC AND VALVULAR HEART DISEASE 303 RENAL CIRCULATION (2010) 323 HYPERTENSION 333 CARDIOMYOPATHY, MYOCARDITIS AND ATRIAL MYXOMA 351 ENDOTHELIUM AND CORONARY CIRCULATION 369 ANGINA PECTORIS 389 DRUGS USEDYear's IN HYPERTENSION 397 SHOCK 399 ADULT CARDIAC LAB 413 CARDIAC ANESTHESIA & BYPASS 421 LastEXERCISE PHYSIOLOGY 431 ISCHEMIC
    [Show full text]
  • Post-Myocardial Infarction Ventricular Remodeling Biomarkers—The Key Link Between Pathophysiology and Clinic
    biomolecules Review Post-Myocardial Infarction Ventricular Remodeling Biomarkers—The Key Link between Pathophysiology and Clinic Maria-Madălina Bostan 1,2, Cristian Stătescu 1,2,* , Larisa Anghel 1,2,*, 3 4 1,2 Ionela-Lăcrămioara S, erban , Elena Cojocaru and Radu Sascău 1 Internal Medicine Department, “Grigore T. Popa” University of Medicine and Pharmacy, 700503 Iasi, Romania; [email protected] (M.-M.B.); [email protected] (R.S.) 2 Cardiology Department, Cardiovascular Diseases Institute “Prof. Dr. George I.M.Georgescu”, 700503 Iasi, Romania 3 Physiology Department, “Grigore T. Popa” University of Medicine and Pharmacy, 700503 Iasi, Romania; ionela.serban@umfiasi.ro 4 Department of Morphofunctional Sciences I—Pathology, “Grigore T. Popa” University of Medicine and Pharmacy, 700503 Iasi, Romania; elena2.cojocaru@umfiasi.ro * Correspondence: [email protected] (C.S.); larisa.anghel@umfiasi.ro (L.A.); Tel.: +40-0232-211834 (C.S. & L.A.) Received: 28 October 2020; Accepted: 18 November 2020; Published: 23 November 2020 Abstract: Studies in recent years have shown increased interest in developing new methods of evaluation, but also in limiting post infarction ventricular remodeling, hoping to improve ventricular function and the further evolution of the patient. This is the point where biomarkers have proven effective in early detection of remodeling phenomena. There are six main processes that promote the remodeling and each of them has specific biomarkers that can be used in predicting the evolution (myocardial necrosis, neurohormonal activation, inflammatory reaction, hypertrophy and fibrosis, apoptosis, mixed processes). Some of the biomarkers such as creatine kinase–myocardial band (CK-MB), troponin, and N-terminal-pro type B natriuretic peptide (NT-proBNP) were so convincing that they immediately found their place in the post infarction patient evaluation protocol.
    [Show full text]
  • Effects of Morphine on Coronary and Left Ventricular Dynamics in Conscious Dogs
    Effects of morphine on coronary and left ventricular dynamics in conscious dogs. S F Vatner, … , J D Marsh, J A Swain J Clin Invest. 1975;55(2):207-217. https://doi.org/10.1172/JCI107923. Research Article We studied the effects of i.v. 2 mg/kg morphine sulfate (MS) on coronary blood flow and resistance, left ventricular (LV) diameter and pressure (P), rate of change of pressure (dP/dt), and dP/dt/P in conscious dogs. An initial transient reduction in coronary vascular resistance, associated with increases in heart rate, dP/dt, dP/dt/P, and reductions in LV end-diastolic and end-systolic size were observed. This was followed by a prolonged increase in mean coronary vascular resistance, lasting from 5 to 30 min, while heart rate, arterial pressure, and LV end-diastolic diameter returned to control levels and dP/dt/P remained slightly but significantly above control. At 10 min, late diastolic coronary flow had fallen from 44 plus or minus 3 ml/min to a minimum level of 25 plus or minus 3 ml/min, while late diastolic coronary resistance had risen from 1.68 plus or minus 0.10 to 3.04 plus or minus 0.28 mm Hg/ml/min. Morphine also induced substantial coronary vasoconstriction when heart rate was held constant. Neither the MS-induced coronary vasoconstriction nor the positive inotropic response was abolished by bilateral adrenalectomy. The positive inotropic response of MS was reversed after beta blockade, but not the coronary vasoconstriction. Alpha receptor blockade abolished the late coronary vasoconstriction effects of morphine, and only dilatation occurred.
    [Show full text]